Applied Clinical Trials December 2017

December 2017 | Volume 26, Issue 12
Applied Clinical Trials November/December 2017
From the Editor
Dealmaking spurt and key upcoming regulatory guidances point the trajectory ahead in clinical research space.
Clinical Trial Insights
Study examines the growing integration of real-world data and evidence and the remaining roadblocks to adoption.    
News
The agency is moving to smooth the pathways for orphan drugs, genetic therapies, and other scientific advances to yield more transformative medicines.
Expert outlines approaches to preventing fraud in clinical research—a more prevalent problem than many believe.
With the literal toss of a coin officially sending the EMA to Amsterdam post-Brexit, it's worth reflecting on what might have been if the decision went differently.
By Applied Clinical Trials Editors
Collaboration focuses on the use of a digital toolset in medication management and patient engagement during studies.
Reference tool is a Rosetta Stone for clinical research. A look at the updates and enhancements in latest version.
Feature Article
Outlining the benefits of using blockchain technology across the supply chain to more securely record and distribute data to sites.
A model to identify the services and resources sites need to conduct high-quality clinical trials.
Weighing overall workplace trends in the life sciences with new survey findings and views on job satisfaction.
Survey uncovers key best practices that sponsors, CROs, and sites should consider when faced with patient enrollment challenges.
A Closing Thought
The ruling by the Pennsylvania Supreme Court requiring informed consent to be obtained by a medical doctor could set a precedent for future nationwide cases involving clinical research.
native1_300x100
lorem ipsum